They offer a research-aligned starting point without locking users into a higher dose
Some users may experience fatigue, headaches, or mild dizziness
By comparison, reports are that Novo Nordisk began offering Wegovy injection at $349/month for cash-pay patients (as of November)
This marks a sharp increase from the 12% who said theyd taken a GLP-1 and 6% who were using a GLP-1 in KFFs May 2024 survey
MAN has participated on advisory boards or has been invited as a speaker by Amylin Pharmaceuticals, AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Diartis Pharmaceuticals Inc., Eli Lilly & Co., GlaxoSmithKline, Hoffmann-La Roche Ltd., Intarcia Therapeutics Inc., Janssen Global Services, MannKind Corp., MSD, Novo Nordisk, Novartis, Sanofi, Takeda, Versartis and Wyeth Research